Amgen: UBS raises target price to $470 from $430
AMGN•UBS raised its target price for Amgen to $470 from $430.
Related News
Oil falls as Trump comments on Iran talks ease supply concerns
USO•
Pfizer: BofA Global Research raises price objective to $29 from $27
PFE•
Moderna: BofA Global Research raises price objective to $200 from $170
MRNA•
Indosat, F5 partner to launch Indosat Intelligence Suite enterprise AI platform across Asia
FFIV•
Nasdaq trading halt continues; reason unavailable at 10:09 a.m.
UCFI•